EXEL, VRNA, ALKS, KNSA, and IMCR are gaining ground as biotech M&A heats up and innovation offsets macro uncertainty.

Alkermes plc (NASDAQ:ALKS – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the twelve ratings firms that are covering the company, Marketbeat reports. Three ...

we recently compiled a list of the 10 Most Undervalued Quality Stocks To Buy According To Analysts. In this article, we will look at where Alkermes (NASDAQ:ALKS) ranks among the most undervalued ...

Alkermes plc (NASDAQ:ALKS) just released its annual report and things are looking bullish. It was overall a positive result, with revenues beating expectations by 3.4% to hit US$1.6b.

But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.Everyone has their own methods for finding great value opportunities, but our ...

Alkermes Price Performance. Spin-Off Research. Post-spin-off, Alkermes (RemainCo) will retain its focus on significant unmet needs within neuroscience and driving the growth of its proprietary ...

The stock price of Alkermes, a biopharmaceutical company focused on neuroscience and oncology, has seen a rise of around 16% over the last twenty-one trading days, and it is up a solid 91% over ...

Alkermes expects that revenue for full-year 2021 will be between $1.1 billion and $1.17 billion. It anticipates GAAP loss per share of $0.53 to $0.78, with adjusted non-GAAP EPS between $0.37 and ...

Alkermes reported slightly weaker-than-expected Q1 results several weeks ago, and the stock quote is down close to -30% since February. The good news for investors is the company: (1) ...

Alkermes, the suit alleges, “intended to mislead the public into believing that Vivitrol was superior to methadone and buprenorphine and to stigmatize those safer and more effective methods of ...

Alkermes will work to advance Rodin's research and expects to incur about $20 million of r&d costs in 2020. The company will provide financial expectations for 2020 in February.